A Possible Mechanism of Adriamycin Cardiotoxicity
In heart muscle, NADP-linked isocitrate dehydrogenase activity is particularly high when compared with that of the other representative NADPH-generating enzyme, glucose-6-phosphate dehydrogenase. Approximately 80% of cardiac NADP-linked isocitrate dehydrogenase activity originates in the mitochondria. Adriamycin inhibited the activity of both mitochondrial and cytoplasmic NADP-linked isocitrate dehydrogenase dose dependently but had no effect on glucose-6-phosphate dehydrogenase. The inhibition was kinetically distinguished as noncompetitive. Preincubation of crude cardiac enzyme preparations with adriamycin enhanced the inhibition time dependently for 45 min. However, there was no evidence to suggest that the metabolites of adriamycin produced in this system were active as inhibitors. Adria-mycin-binding protein was fractionated by affinity chromatography, but NADP-linked isocitrate dehydrogenase activity was not detected in this fraction.
KeywordsCyanogen Bromide Isobutyric Acid Ethyl Formate Isocitric Acid ICDH Activity
Unable to display preview. Download preview PDF.
- 2.Asbell, M. A., Schwartzbach, E., Bullock, F. J., and Yesair, D. W., 1972. Daunomycin and adriamycin metabolism via reductive glycosidic cleavage. J. Pharmacol. Ther. 182:63–69.Google Scholar
- 3.Atassi, G., and Tagnon, H. J. 1974. Comparison of adriamycin with the DNA-adriamycin complex in chemotherapy of L 1210 leukemia. Europ. J. Cancer. 10:399–403.Google Scholar
- 11.Di Marco, A., Gaetani, M., and Scarpinate, B. 1969. Adriamycin (NSC-123, 127): A new antibiotic with antitumor activity. Cancer Chemother. Rep. [Part 1] 53:33–37.Google Scholar
- 12.Edwin, E. E., Diplock, A. T., Bunyan, J., and Green, J. 1961. Studies on vitamin E. Biochem. J. 79:91–104.Google Scholar
- 13.Gloch, G. H., and Mc Lean, P. 1953. Further studies on the properties and assay of glucose-6-phosphate dehydrogenase and 6 phosphogluconate dehydrogenase of rat liver. Biochem. J. 55:400–408.Google Scholar
- 15.Gosolvez, M., Van Rossam, G. D. V., and Blanco, M. F., 1979. Inhibition of sodium-potassium activated adenosine 5′ triphosphate and ion transport by adriamycin. Cancer Res. 39:257–261.Google Scholar
- 17.Kajiwara, H., Shimamoto, F., and Nakagami, K. 1980. Aclacinomycin cardiomyopathy. In: Abstracts, 3rd Congress of Cardiac Metabolism, Kyoto, Japan, p. 20.Google Scholar
- 22.Negishi, T., and Takahira, H. 1973. [The absorption, excretion, distribution and metabolism of adriamycin.] Kiso To Rinsho 7:425–431.Google Scholar
- 25.Yasumi, M., Minaga, T., Nakamura, K., Kimura, I., Maeda, M., Yoneda, S., Kizu, A., and Ijichi, H. 1980. The studies on cardiotoxicity by adriamycin. In: Abstracts, 3rd Congress of Cardiac Metabolism, Kyoto, Japan, p. 19.Google Scholar